These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes. Kasprzycka M; Zhang Q; Witkiewicz A; Marzec M; Potoczek M; Liu X; Wang HY; Milone M; Basu S; Mauger J; Choi JK; Abrams JT; Hou JS; Rook AH; Vonderheid E; Woetmann A; Odum N; Wasik MA J Immunol; 2008 Aug; 181(4):2506-12. PubMed ID: 18684941 [TBL] [Abstract][Full Text] [Related]
3. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Edelson RL Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Ahn JS; Krishnadas DK; Agrawal B Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657 [TBL] [Abstract][Full Text] [Related]
5. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. Koenen HJ; Fasse E; Joosten I J Immunol; 2003 Dec; 171(12):6431-41. PubMed ID: 14662842 [TBL] [Abstract][Full Text] [Related]
6. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Berger CL; Hanlon D; Kanada D; Dhodapkar M; Lombillo V; Wang N; Christensen I; Howe G; Crouch J; El-Fishawy P; Edelson R Blood; 2002 Apr; 99(8):2929-39. PubMed ID: 11929784 [TBL] [Abstract][Full Text] [Related]
7. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574 [TBL] [Abstract][Full Text] [Related]
8. The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy. Berger CL; Edelson R Curr Cancer Drug Targets; 2004 Nov; 4(7):609-19. PubMed ID: 15578918 [TBL] [Abstract][Full Text] [Related]
9. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene. Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755 [TBL] [Abstract][Full Text] [Related]
10. High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma. Schlapbach C; Ochsenbein A; Kaelin U; Hassan AS; Hunger RE; Yawalkar N J Am Acad Dermatol; 2010 Jun; 62(6):995-1004. PubMed ID: 20466174 [TBL] [Abstract][Full Text] [Related]
11. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma. Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332 [TBL] [Abstract][Full Text] [Related]
12. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Abraham RM; Zhang Q; Odum N; Wasik MA Cancer Biol Ther; 2011 Dec; 12(12):1019-22. PubMed ID: 22236880 [TBL] [Abstract][Full Text] [Related]
13. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Bagot M; Nikolova M; Schirm-Chabanette F; Wechsler J; Boumsell L; Bensussan A Ann N Y Acad Sci; 2001 Sep; 941():31-8. PubMed ID: 11594580 [TBL] [Abstract][Full Text] [Related]
14. Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation. Perez N; Karumuthil-Melethil S; Li R; Prabhakar BS; Holterman MJ; Vasu C J Immunol; 2008 May; 180(10):6566-76. PubMed ID: 18453575 [TBL] [Abstract][Full Text] [Related]
15. Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells. Shimauchi T; Kabashima K; Tokura Y Cancer Sci; 2008 Jan; 99(1):98-106. PubMed ID: 17970785 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. Zou T; Caton AJ; Koretzky GA; Kambayashi T J Immunol; 2010 Sep; 185(5):2790-9. PubMed ID: 20686126 [TBL] [Abstract][Full Text] [Related]
18. IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets. Ye Z; Huang H; Hao S; Xu S; Yu H; Van Den Hurk S; Xiang J J Interferon Cytokine Res; 2007 Dec; 27(12):1031-8. PubMed ID: 18184044 [TBL] [Abstract][Full Text] [Related]
19. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4. Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658 [TBL] [Abstract][Full Text] [Related]
20. Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma. Tiemessen MM; Mitchell TJ; Hendry L; Whittaker SJ; Taams LS; John S J Invest Dermatol; 2006 Oct; 126(10):2217-23. PubMed ID: 16741512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]